Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Conflict of interest statement Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: TAK has received research support from the CIHR, the International Life Science Institute and National Honey Board. He has been an invited speaker at the Calorie Control Council Annual meeting for which he has received an honorarium.
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Pulmonary embolism (PE) is the third-leading cause of cardiovascular death in the United States, with an annual mortality of approximately 100,000 people per year.1 While anticoagulation is the primary treatment for acute pulmonary embolism, additional reperfusion strategies exist, including systemic thrombolysis, surgical embolectomy, extracorporeal membrane oxygenation (ECMO) and catheter-directed therapies.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
